APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
about
Infection-Related Focal Segmental Glomerulosclerosis in ChildrenKidney function is associated with an altered protein composition of high-density lipoprotein.APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.The Cell Biology of APOL1.APOL1 Nephrotoxicity: What Does Ion Transport Have to Do With It?ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.A mouse recapitulating APOL1-associated kidney disease.Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.APOL1 and Proteinuria in the AASK: Unraveling the Pathobiology of APOL1.Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.Identifying the Intracellular Function of APOL1.Molecular Mechanisms of Injury in HIV-Associated Nephropathy.APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKDAPOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R
P2860
Q26746638-6233C11A-2AFF-41B8-AC8A-908E2DB3BB15Q38650168-53E4E251-F4B0-40E5-956E-63F3CDA2B7D8Q40127447-2F0F7C80-25E8-45DF-ACA2-66980CCE2842Q40145523-4FFEF7C5-E5AD-4CB7-B0AC-EE444D776EDEQ40184938-959BC472-EF84-4ED3-918D-AB383D1A3FE7Q40749201-3083DFB0-4239-4BA4-92AA-27902F591F83Q46413738-856C85FE-3F00-440D-8735-88AD87E88585Q46737437-86825E8A-03DE-480C-A1EF-A74AD768EC5FQ46751578-648C7D7B-4946-435D-B543-2740739C1DD0Q46894710-9FBEA9C9-1638-460F-A3C4-9C869C7852F4Q47359082-D6EFCE4A-F2FA-46A5-AAB3-64AE9878A379Q48304101-51F5A090-B701-467D-AF0C-EA88AFA18384Q48507049-69448C84-7BA7-4E0E-808E-97758CD28002Q49215238-233AE9D3-FC92-470E-816C-4B6DDC468B5DQ50099449-85EA95EE-6B64-4F9F-ACBD-23C484529D9BQ50183550-7AB20B46-9310-4976-860A-388A9DC84358Q52715295-0DCEC9CA-92EA-4F30-8DAC-0CD8B761559EQ54145206-7A5465B3-BE37-45DB-B880-51D548F0A510Q55405435-9032C295-EC04-4268-B622-9478C0971B08Q57785854-983677DC-8DCE-43E2-8E0C-7AE192C7A68FQ58699823-FF93DFEB-9546-4F83-A802-6366FA4452DD
P2860
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@en
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@nl
type
label
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@en
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@nl
prefLabel
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@en
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@nl
P2093
P2860
P356
P1476
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
@en
P2093
David B Thomas
John F O'Toole
John R Sedor
Laura Barisoni
Leslie A Bruggeman
Liping Luo
Martha Konieczkowski
Paul E Drawz
Sethu M Madhavan
Zhenzhen Wu
P2860
P304
P356
10.1681/ASN.2015111220
P577
2016-03-29T00:00:00Z